Notably, Novo Nordisk's asserted potential to capitalize on the compounded market greatly understated the potential impact of the personalization exception to the compounded GLP-1 exclusion and ...
2025-08-08 15.15.45CESTNovo Nordisk A/S - Managers' Transactions Novo Nordisk A/S. Trading in Novo Nordisk shares by board members, executives and associated persons ... a) Name Novo Nordisk A/S ... Identification code Novo Nordisk B DK0062498333.
... to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons.
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE. NVO) of a class action securities lawsuit ... .